Rodgers Brothers’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.3M | Sell |
102,245
-28,071
| -22% | -$3.24M | 1.42% | 14 |
|
|
2025
Q4 | $13.7M | Sell |
130,316
-2,970
| -2% | -$279K | 1.64% | 11 |
|
|
2025
Q3 | $11.2M | Sell |
133,286
-2,326
| -2% | -$192K | 1.38% | 13 |
|
|
2025
Q2 | $10.7M | Buy |
135,612
+2,977
| +2% | +$237K | 1.35% | 12 |
|
|
2025
Q1 | $11.9M | Buy |
132,635
+3,441
| +3% | +$321K | 1.59% | 11 |
|
|
2024
Q4 | $12.9M | Buy |
129,194
+18,697
| +17% | +$1.93M | 1.68% | 12 |
|
|
2024
Q3 | $12.5M | Buy |
110,497
+28,688
| +35% | +$3.41M | 1.59% | 10 |
|
|
2024
Q2 | $10.1M | Sell |
81,809
-475
| -0.6% | -$61.2K | 1.37% | 11 |
|
|
2024
Q1 | $10.9M | Sell |
82,284
-19,829
| -19% | -$2.44M | 1.48% | 11 |
|
|
2023
Q4 | $11.1M | Buy |
102,113
+23,078
| +29% | +$2.4M | 1.76% | 10 |
|
|
2023
Q3 | $8.14M | Buy |
79,035
+9,257
| +13% | +$998K | 1.39% | 13 |
|
|
2023
Q2 | $8.05M | Buy |
69,778
+8,638
| +14% | +$981K | 1.42% | 13 |
|
|
2023
Q1 | $6.5M | Buy |
61,140
+2,062
| +3% | +$223K | 1.25% | 21 |
|
|
2022
Q4 | $6.55M | Sell |
59,078
-47
| -0.1% | -$4.8K | 1.32% | 19 |
|
|
2022
Q3 | $5.09M | Buy |
59,125
+925
| +2% | +$82.6K | 1.08% | 25 |
|
|
2022
Q2 | $5.31M | Sell |
58,200
-24,956
| -30% | -$2.21M | 1.05% | 27 |
|
|
2022
Q1 | $6.82M | Buy |
83,156
+50
| +0.1% | +$3.94K | 1.23% | 23 |
|
|
2021
Q4 | $6.37M | Sell |
83,106
-6,839
| -8% | -$545K | 1.13% | 25 |
|
|
2021
Q3 | $6.76M | Buy |
89,945
+1,000
| +1% | +$76.1K | 1.35% | 20 |
|
|
2021
Q2 | $6.92M | Sell |
88,945
-5,134
| -5% | -$382K | 1.32% | 21 |
|
|
2021
Q1 | $6.92M | Buy |
94,079
+16,349
| +21% | +$1.21M | 1.43% | 20 |
|
|
2020
Q4 | $6.07M | Buy |
77,730
+5,056
| +7% | +$387K | 1.39% | 18 |
|
|
2020
Q3 | $5.75M | Buy |
72,674
+11,437
| +19% | +$896K | 1.49% | 18 |
|
|
2020
Q2 | $4.52M | Sell |
61,237
-298
| -0.5% | -$22.4K | 1.22% | 22 |
|
|
2020
Q1 | $4.52M | Buy |
61,535
+7,297
| +13% | +$573K | 1.43% | 19 |
|
|
2019
Q4 | $4.71M | Buy |
54,238
+828
| +2% | +$68K | 1.22% | 26 |
|
|
2019
Q3 | $4.29M | Sell |
53,410
-5,565
| -9% | -$446K | 1.19% | 27 |
|
|
2019
Q2 | $4.72M | Buy |
58,975
+1,367
| +2% | +$105K | 1.31% | 24 |
|
|
2019
Q1 | $4.57M | Sell |
57,608
-1,604
| -3% | -$120K | 1.3% | 24 |
|
|
2018
Q4 | $4.32M | Buy |
59,212
+117
| +0.2% | +$8.26K | 1.39% | 22 |
|
|
2018
Q3 | $4M | Buy |
59,095
+12
| +0% | +$765 | 1.15% | 27 |
|
|
2018
Q2 | $3.42M | Buy |
59,083
+3,264
| +6% | +$184K | 1.04% | 28 |
|
|
2018
Q1 | $2.9M | Buy |
55,819
+6,258
| +13% | +$338K | 0.95% | 32 |
|
|
2017
Q4 | $2.66M | Buy |
49,561
+26,976
| +119% | +$1.5M | 0.87% | 37 |
|
|
2017
Q3 | $1.38M | Buy |
22,585
+1,469
| +7% | +$89.1K | 0.49% | 55 |
|
|
2017
Q2 | $1.29M | Buy |
21,116
+2
| +0% | +$122 | 0.48% | 55 |
|
|
2017
Q1 | $1.28M | Buy |
21,114
+3
| +0% | +$182 | 0.48% | 56 |
|
|
2016
Q4 | $1.19M | Sell |
21,111
-522
| -2% | -$30.5K | 0.47% | 59 |
|
|
2016
Q3 | $1.29M | Buy |
21,633
+3
| +0% | +$175 | 0.52% | 52 |
|
|
2016
Q2 | $1.19M | Sell |
21,630
-108
| -0.5% | -$5.75K | 0.49% | 53 |
|
|
2016
Q1 | $1.1M | Buy |
21,738
+1,366
| +7% | +$66.9K | 0.48% | 50 |
|
|
2015
Q4 | $1.03M | Buy |
20,372
+7,339
| +56% | +$370K | 0.48% | 56 |
|
|
2015
Q3 | $614K | Buy |
13,033
+421
| +3% | +$22.4K | 0.31% | 75 |
|
|
2015
Q2 | $685K | Buy |
12,612
+4,769
| +61% | +$267K | 0.32% | 71 |
|
|
2015
Q1 | $430K | Hold |
7,843
| – | – | 0.21% | 98 |
|
|
2014
Q4 | $425K | Hold |
7,843
| – | – | 0.21% | 95 |
|
|
2014
Q3 | $444K | Hold |
7,843
| – | – | 0.23% | 91 |
|
|
2014
Q2 | $433K | Hold |
7,843
| – | – | 0.21% | 99 |
|
|
2014
Q1 | $425K | Sell |
7,843
-3,837
| -33% | -$199K | 0.2% | 99 |
|
|
2013
Q4 | $558K | Buy |
11,680
+5
| +0% | +$229 | 0.28% | 80 |
|
|
2013
Q3 | $530K | Buy |
11,675
+2,420
| +26% | +$110K | 0.29% | 80 |
|
|
2013
Q2 | $410K | Buy |
+9,255
| New | +$413K | 0.24% | 84 |
|
Other funds holding MRK
VCM
VPM
Rodgers Brothers's MRK Position: Q1 2026 in Review
Rodgers Brothers reduced its Merck (MRK) stake by 22% in Q1 2026, selling an estimated $3.24M and leaving 102,245 shares worth $12.3M. The position accounts for 1.42% of the portfolio, ranked #14.
Rodgers Brothers first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $13.7M in Q4 2025. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Rodgers Brothers held 102,245 shares of Merck worth $12.3M as of Q1 2026.
- Rodgers Brothers sold 28,071 Merck shares in Q1 2026, an estimated $3.24M.
- Merck made up 1.42% of Rodgers Brothers's portfolio in Q1 2026, its #14 holding.
- Rodgers Brothers first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
- Rodgers Brothers's Merck position peaked at $13.7M in Q4 2025.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Rodgers Brothers's 13F filing for Q1 2026, filed 14 May 2026.